Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome

Transplant International

Volumn 24, Issue 9, 2011, Pages 932-942

  Moroso, Viviana ^a   Van Der Meer, Arnold ^b   Tilanus, Hugo W ^a   Kazemier, Geert ^a   Van Der Laan, Luc J W ^a   Metselaar, Herold J ^a   Joosten, Irma ^b   Kwekkeboom, Jaap ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

human leukocyte antigen C; killer cell immunoglobulin like receptors; liver transplantation; natural killer

Indexed keywords

HLA ANTIGEN; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ADOLESCENT; ADULT; AGED; ALLOGRAFT; ALLOIMMUNITY; ARTICLE; FEMALE; GENOTYPE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HLA-B ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECEPTORS, KIR; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 80051700613     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2011.01286.x     Document Type: Article

References (60)

1. Heeger PS,. What's new and what's hot in transplantation: basic science ATC 2003. Am J Transplant 2003; 3: 1474.
2. Rosen HR,. Transplantation immunology: what the clinician needs to know for immunotherapy. Gastroenterology 2008; 134: 1789.
3. Velardi A, Ruggeri L, Moretta A, Moretta L,. NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol 2002; 23: 438.
4. Heidecke CD, Araujo JL, Kupiec-Weglinski JW, et al. Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts. Transplantation 1985; 40: 441.
5. Zijlstra M, Auchincloss Jr H, Loring JM, Chase CM, Russell PS, Jaenisch R,. Skin graft rejection by beta 2-microglobulin-deficient mice. J Exp Med 1992; 175: 885.
6. Kitchens WH, Uehara S, Chase CM, Colvin RB, Russell PS, Madsen JC,. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 2006; 81: 811.
7. -/- mice. Nat Med 2001; 7: 557.
8. Coudert JD, Coureau C, Guery JC,. Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th type 2 responses to transplantation antigens. J Immunol 2002; 169: 2979.
9. Beilke JN, Kuhl NR, Van Kaer L, Gill RG,. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 2005; 11: 1059.
10. Yu G, Xu X, Vu MD, Kilpatrick ED, Li XC,. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006; 203: 1851.
11. Laffont S, Seillet C, Ortaldo J, Coudert JD, Guery JC,. Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood 2008; 112: 661.
12. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (New York, NY) 2002; 295: 2097.
13. Ruggeri L, Mancusi A, Burchielli E, et al. NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. Blood Cells Mol Dis 2008; 40: 84.
14. Ruggeri L, Mancusi A, Capanni M, et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood 2007; 110: 433.
15. Chan EY, Larson AM, Gernsheimer TB, et al. Recipient and donor factors influence the incidence of graft-versus-host disease in liver transplant patients. Liver Transpl 2007; 13: 516.
16. Kohler S, Pascher A, Junge G, et al. Graft versus host disease after liver transplantation-a single center experience and review of literature. Transpl Int 2008; 21: 441.
17. Moroso V, Metselaar HJ, Mancham S, et al. Liver grafts contain a unique subset of natural killer cells that are transferred into the recipient after liver transplantation. Liver Transpl 2010; 16: 895.
18. Rajalingam R,. Variable interactions of recipient killer cell immunoglobulin-like receptors with self and allogenic human leukocyte antigen class I ligands may influence the outcome of solid organ transplants. Curr Opin Organ Transplant 2008; 13: 430.
19. Villard J,. The role of natural killer cells in human solid organ and tissue transplantation. J Innate Immun 2011; in press.
20. Kunert K, Seiler M, Mashreghi MF, et al. KIR/HLA ligand incompatibility in kidney transplantation. Transplantation 2007; 84: 1527.
21. Kreijveld E, van der Meer A, Tijssen HJ, Hilbrands LB, Joosten I,. KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation. Transplantation 2007; 84: 1045.
22. Tran TH, Mytilineos J, Scherer S, Laux G, Middleton D, Opelz G,. Analysis of KIR ligand incompatibility in human renal transplantation. Transplantation 2005; 80: 1121.
23. Bishara A, Brautbar C, Zamir G, Eid A, Safadi R,. Impact of HLA-C and Bw epitopes disparity on liver transplantation outcome. Hum Immunol 2005; 66: 1099.
24. Hanvesakul R, Spencer N, Cook M, et al. Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation. Am J Transplant 2008; 8: 1931.
25. Oertel M, Kohlhaw K, Diepolder HM, et al. Alloreactivity of natural killer cells in allogeneic liver transplantation. Transplantation 2001; 72: 116.
26. Lopez-Alvarez MR, Moya-Quiles MR, Minguela A, et al. HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+ KIR2D+ T-cells recuperation. Transplantation 2009; 88: S54.
27. Tran TH, Middleton D, Dohler B, et al. Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival. Am J Transplant 2009; 9: 1674.
28. van der Meer A, Schaap NP, Schattenberg AV, van Cranenbroek B, Tijssen HJ, Joosten I,. KIR2DS5 is associated with leukemia free survival after HLA identical stem cell transplantation in chronic myeloid leukemia patients. Mol Immunol 2008; 45: 3631.
29. de Arias AE, Haworth SE, Belli LS, et al. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. Liver Transpl 2009; 15: 390.
30. Carrega P, Pezzino G, Queirolo P, et al. Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells. PLoS ONE 2009; 4: e8132.
31. Yu J, Venstrom JM, Liu XR, et al. Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation. Blood 2009; 113: 3875.
32. Ahlenstiel G, Martin MP, Gao X, Carrington M, Rehermann B,. Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest 2008; 118: 1017.
33. Hiby SE, Regan L, Lo W, Farrell L, Carrington M, Moffett A,. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod 2008; 23: 972.
34. Hsu KC, Chida S, Geraghty DE, Dupont B,. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002; 190: 40.
35. Uhrberg M, Parham P, Wernet P,. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002; 54: 221.
36. Kroemer A, Edtinger K, Li XC,. The innate natural killer cells in transplant rejection and tolerance induction. Curr Opin Organ Transplant 2008; 13: 339.
37. van der Touw W, Bromberg JS,. Natural killer cells and the immune response in solid organ transplantation. Am J Transplant 2010; 10: 1354.
38. LaRosa DF, Rahman AH, Turka LA,. The innate immune system in allograft rejection and tolerance. J Immunol 2007; 178: 7503.
39. Gill RG,. NK cells: elusive participants in transplantation immunity and tolerance. Curr Opin Immunol 2010; 22: 649.
40. Kumar N, Wall WJ, Grant DR, et al. Liver retransplantation. Transpl Proc 1999; 31: 541.
41. McCashland T, Watt K, Lyden E, et al. Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. Liver Transpl 2007; 13: 1246.
42. Anfossi N, Andre P, Guia S, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006; 25: 331.
43. Brodin P, Karre K, Hoglund P,. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol 2009; 30: 143.
44. Fauriat C, Long EO, Ljunggren HG, Bryceson YT,. Regulation of human NK cell cytokine and chemokine productionby target cell recognition. Blood 2010; 115: 2167.
45. Andersson S, Fauriat C, Malmberg JA, Ljunggren HG, Malmberg KJ,. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood 2009; 114: 95.
46. Draghi M, Yawata N, Gleimer M, Yawata M, Valiante NM, Parham P,. Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I. Blood 2005; 105: 2028.
47. Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, Parham P,. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 2006; 203: 633.
48. Vitale M, Carlomagno S, Falco M, et al. Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2. Int Immunol 2004; 16: 1459.
49. Joncker NT, Fernandez NC, Treiner E, Vivier E, Raulet DH,. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J Immunol 2009; 182: 4572.
50. Morvan M, David G, Sebille V, et al. Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions. Eur J Immunol 2008; 38: 3474.
51. Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC,. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol 2007; 179: 5977.
52. Bonorino P, Ramzan M, Camous X, et al. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J Hepatol 2009; 51: 458.
53. Cheent K, Khakoo SI,. Natural killer cells and hepatitis C: action and reaction. Gut 2011; 60: 268.
54. Nellore A, Fishman JA,. NK cells, innate immunity and hepatitis C infection after liver transplantation. Clin Infect Dis 2011; 52: 369.
55. Pratschke J, Stauch D, Kotsch K,. Role of NK and NKT cells in solid organ transplantation. Transpl Int 2009; 22: 859.
56. Czaja AJ,. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl 2002; 8: 505.
57. Sun JC, Lanier LL,. Cutting edge: viral infection breaks NK cell tolerance to 'missing self'. J Immunol 2008; 181: 7453.
58. Luther SA, Acha-Orbea H,. Immune response to mouse mammary tumour virus. Curr Opin Immunol 1996; 8: 498.
59. Xu L, Sakalian M, Shen Z, Loss G, Neuberger J, Mason A,. Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. Hepatology (Baltimore, Md) 2004; 39: 151.
60. Mendel JB, Chavin KD, Bratton C, Knechtle SJ,. HLA-C and liver transplant outcomes: interpreting the facts. Am J Transplant 2009; 9: 1491.